Tregs
Showing 1 - 25 of 382
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Tregs CD25 CXCL9 in Vitiligo
Not yet recruiting
- Vitiligo
- +3 more
- ELIZA , Flowcytometry
- (no location specified)
Oct 3, 2022
Liver Transplant Trial in San Francisco (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 13, 2022
Aplastic Anemia Trial in London (Expanded autologous T regulatory cells)
Recruiting
- Aplastic Anemia
- Expanded autologous T regulatory cells
-
London, United KingdomKing's College Hospital
Aug 16, 2022
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)
Recruiting
- Living Donor Kidney Transplantation
- Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
-
Palo Alto, California
- +1 more
May 6, 2022
Multiple Sclerosis, Relapsing-Remitting, Adult ALL, Vitamin D3 Deficiency Trial (25(OH)D3, vitamin D3)
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- +2 more
- 25(OH)D3
- vitamin D3
- (no location specified)
Apr 16, 2022
Kidney Transplant Rejection, End Stage Renal Disease Trial in Belgium, Netherlands, United Kingdom (TX200-TR101)
Recruiting
- Kidney Transplant Rejection
- End Stage Renal Disease
- TX200-TR101
-
Leuven, Belgium
- +4 more
Sep 30, 2022
Liver Transplant Recipient, Living Donor (of the Respective Liver Transplant Recipient) Trial in San Francisco, Chicago,
Completed
- Liver Transplant Recipient
- Living Donor (of the Respective Liver Transplant Recipient)
- darTregs
- +4 more
-
San Francisco, California
- +2 more
Jan 21, 2021
Type 1 Diabetes Trial in San Francisco, New Haven (PolyTregs+IL-2)
Completed
- Type 1 Diabetes Mellitus
- PolyTregs+IL-2
-
San Francisco, California
- +1 more
Oct 15, 2021
Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)
Completed
- Leukemia
- Lymphoma
- Rituximab
- +10 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2021
Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV Trial in Chapel Hill, Columbus (Cryopreserved Ex Vivo
Recruiting
- Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
- Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells
-
Chapel Hill, North Carolina
- +1 more
Oct 15, 2021
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022
Active Rheumatoid Arthritis Trial in Tanta (Ergocalciferol 1.25 mg tablet)
Completed
- Active Rheumatoid Arthritis
- Ergocalciferol 1.25 mg tablet
-
Tanta, EL-gharbia, EgyptSouzan Ezzat Gado
Jul 14, 2020
Allergic Rhinoconjunctivitis to Birch Pollen, With a Positive Skin Prick Test to Birch Pollen Trial in Paris (ILT-101 ld-(IL2))
Completed
- Allergic Rhinoconjunctivitis to Birch Pollen
- With a Positive Skin Prick Test to Birch Pollen
- ILT-101 ld-(IL2)
-
Paris, FranceCIC Paris Est GH Pitié Salpétrière
Dec 13, 2022
Late Complication From Kidney Transplant Trial in San Francisco (Treg infusion)
Completed
- Late Complication From Kidney Transplant
- Treg infusion
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 11, 2022
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute
Recruiting
- Acute Rejection of Renal Transplant
- Graft Failure
- Donor-derived cell-free DNA
-
Loma Linda, CaliforniaLoma Linda University Health
Jul 19, 2022
Liver Cirrhosis Trial in Nanjing (MSC and Tregs)
Not yet recruiting
- Liver Cirrhosis
- MSC and Tregs
-
Nanjing, Jiangsu, ChinaNanjing Medical University
Mar 1, 2020
Diabetes type1 Trial (cePolytreg)
Not yet recruiting
- Diabetes type1
- cePolytreg
- (no location specified)
Jul 8, 2022
Rheumatoid Arthritis, Swelling Joint, Joint Fluid Trial in Montpellier (Exploratory synovial fluid analysis)
Recruiting
- Rheumatoid Arthritis
- +3 more
- Exploratory synovial fluid analysis
-
Montpellier, FranceLapeyronie Hospital
Jan 12, 2022
Microparticle Delivered STING Agonist in Control of Experimental
Recruiting
- Relapse Remitting Multiple Sclerosis
- Blood Draw
-
Philadelphia, PennsylvaniaThomas Jefferson University
Jan 20, 2023
Type 1 Diabetes Trial in Worldwide (rhIL-2, Placebo)
Active, not recruiting
- Type 1 Diabetes
- rhIL-2
- Placebo
-
Liège, Province De Liège, Belgium
- +33 more
Feb 9, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Minneapolis (Cyclophosphamide, Cetuximab)
Completed
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Sep 10, 2019
Interleukins in Periodontal Disease Progression
Recruiting
- Periodontitis
- Gingivitis
- Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
-
Assiut, Asyut, EgyptDepartment of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023
Healthy Volunteers Trial in Paris (ILT101, Placebo)
Completed
- Healthy Volunteers
- ILT101
- Placebo
-
Paris, FranceClinical Investigation Center Paris Est Hôpital Universitaire Pi
Dec 10, 2021